How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XB

NASDAQ:XBIT
Get a brief AI stock analysisSaves ~ 15 minutes of your time

XB

XBiotech IncNASDAQ XBIT Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is XBIT undervalued compared to its fair value?

The fair value of XBIT stock is hidden USD. Relative to the market price of 6.21 USD XBiotech Inc is hidden.

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. The company is headquartered in Austin, Texas and currently employs 85 full-time employees....[More about valuation]

XBiotech Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.204 $B

Price:

6.21 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.242

FINANCIALS

XBiotech financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0085 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0074 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.23 B
0.22 B

Financial Position Analysis

Assets

0.23 B
Current Assets
0.2 B
Total non-current assets
0.025 B

Total current liabilities
0.0053 B
Total non-current liabilities
0.0016 B

Cash Flow Statement

-0.0015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

XBiotech fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-10 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-159 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-10 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is XBIT attractive for investment based on fundamental analysis?

XBIT stock rating is hidden. XBiotech is a hidden by Eyestock methodology.

Get XBIT Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-7 707

Gross Margin:

93

CFO / Debt ratio:

hidden

Current ratio:

48.571

Debt / Equity ratio:

ROE:

-10

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

XBIT analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for XBIT to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

XBiotech Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

XBiotech Inc dividends

XBiotech Inc dividend yield is 16.06%

The annual dividend is 2.50 USD

XBIT dividend metrics

Payout ratio
-612.62%
Dividend yield
16.06%
Annual dividend
2.50
Dividend streak
1 year
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About XBIT stock

About the company XBiotech Inc

Market cap $B

0.204

Dividend yield

16.06 %

Shares outstanding

30.4393 B

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. The company is headquartered in Austin, Texas and currently employs 85 full-time employees. The company went IPO on 2015-04-15. The firm is focused on the therapies that block a potent substance naturally produced by body, known as interleukin-1 alpha (IL-1a), that mediates tissue breakdown, angiogenesis, the formation of blood clots and inflammation. IL-1a is a protein that is on or in cells of the body and is involved in the body’s response to injury or trauma. Its True Human antibodies have the potential to harness the body's natural immunity to fight disease with increased safety, efficacy and tolerability. The firm has developed a pipeline of product candidates targeting both inflammatory and infectious diseases. The firm is developing a pipeline of product candidates targeting both inflammatory and infectious diseases and has developed commercial scale manufacturing technology and infrastructure.

XBIT profile

  • Ticker

    XBIT

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    15 April 2015

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    85

  • City

    Austin

  • Address

    5217 Winnebago Lane

  • Cusip

    98400H102